Myo-inositol does not stop periods. In fact, it does the opposite for most people who take it: it helps bring periods back or make them more regular, particularly in women with polycystic ovary syndrome (PCOS). A meta-analysis of randomized trials found that women taking inositol were nearly seven times more likely to see increased menstrual frequency compared to those on placebo.1PubMed. Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta-analysis of randomised trials The confusion likely arises because myo-inositol sits in an unusual category, a supplement that meaningfully shifts hormonal patterns, and anything that changes your hormones naturally raises the question of what it might do to your cycle.
Why Myo-Inositol Affects the Menstrual Cycle at All
Myo-inositol (MI) is a sugar alcohol your body already makes. It shows up in fruits, grains, and beans, and your kidneys produce a baseline supply. What makes it relevant to menstrual health is where it works: in the ovary, MI acts as a second messenger for follicle-stimulating hormone (FSH), the signal that tells your ovaries to mature an egg each month.2Trends in Endocrinology & Metabolism. Physiologic Roles of Myo-Inositol and D-Chiro-Inositol in Polycystic Ovary Syndrome When MI levels in ovarian tissue are adequate, FSH signaling works properly, an egg matures, ovulation happens, and a period follows about two weeks later. When MI is depleted or its signaling is disrupted, the chain breaks down.
MI also plays a role in how cells respond to insulin. Insulin resistance, which is common in PCOS but also shows up in other metabolic conditions, depletes inositol stores in certain tissues. That depletion impairs the FSH pathway and contributes to the hormonal imbalance that stalls ovulation. Supplementing with MI essentially restocks what insulin resistance drains, letting the ovary’s normal signaling resume.
The Evidence for Cycle Restoration in PCOS
Most of the clinical research on myo-inositol and menstrual cycles focuses on women with PCOS, the most common hormonal disorder in reproductive-age women and a leading cause of irregular or absent periods. The results across studies are consistently positive, though the size of the effect varies.
In a prospective study of 90 women with PCOS, about 69% restored menstrual cycle regularity after MI supplementation. Among those who had no periods at all (amenorrhea), the response was even stronger: 79% of amenorrheic patients had a spontaneous return of menses.3PubMed Central. The Effectiveness of Myo-Inositol in Women With Polycystic Ovary Syndrome: A Prospective Clinical Study Another study found that 88% of patients restored at least one spontaneous menstrual cycle during treatment, with 72% maintaining normal ovulatory activity even during the follow-up period after stopping.4PubMed. Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction That persistence after stopping is worth noting, since it suggests that MI can help reset the ovarian cycle rather than just mask the problem while you take it.
A larger study looking at combined MI and D-chiro-inositol (DCI) supplementation in Indian women reported that about 81% of participants had their menstruation restored.5PubMed Central. Management of polycystic ovary syndrome among Indian women using myo‐inositol and D-chiro-inositol A systematic review and meta-analysis of randomized controlled trials confirmed the broader pattern: women taking inositols were roughly 1.8 times more likely to achieve a regular menstrual cycle compared to placebo.6PubMed Central. Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials
So the consistent finding is that MI promotes periods rather than suppresses them. If someone notices a temporary disruption in their cycle after starting MI, that likely reflects the hormone recalibration underway rather than the supplement itself halting menstruation.
What Happens to Androgens and Other Hormones
The cycle-restoring effect doesn’t happen in isolation. MI reshapes the broader hormonal landscape that governs menstruation. In a double-blind trial, women taking MI saw their total testosterone drop from about 100 ng/dL to roughly 35 ng/dL, while the placebo group barely budged.7PubMed. Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial That’s a dramatic reduction. Excess androgens (testosterone and related hormones) are one of the main reasons PCOS disrupts ovulation, so driving them down helps unlock the cycle.
Other hormonal shifts follow the same pattern. MI supplementation reduces luteinizing hormone (LH), which tends to be abnormally elevated in PCOS, while also lowering prolactin and fasting insulin levels.8PubMed. Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome Combined MI and DCI therapy has been shown to increase estradiol while decreasing free testosterone and the LH-to-FSH ratio.9PubMed Central. A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women When LH drops and the LH/FSH ratio normalizes, the ovary gets a clearer signal to mature and release an egg. The period that follows is a downstream consequence of that corrected signaling.
How MI Compares to Metformin
Metformin is the most commonly prescribed insulin-sensitizing drug for PCOS. Naturally, researchers have compared it head-to-head with myo-inositol. The short version: they perform similarly for cycle regulation, and MI tends to be better tolerated.
One study found that about 90% of women on MI achieved regular cycles after treatment, compared to about 93% on metformin, a difference that was not statistically meaningful.10PubMed Central. The Comparative Effects of Myo-Inositol and Metformin Therapy on the Clinical and Biochemical Parameters of Women of Normal Weight Suffering from Polycystic Ovary Syndrome Another study found both treatments normalized the cycle in about half of participants, again with no significant difference between them.11PubMed. Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS) A systematic review covering multiple studies reported a slight edge for the MI plus DCI combination, with a 20% increase in women achieving regular cycles over 24 weeks versus 12% for metformin.12UERMMHS Journal. Efficacy and Safety of Myo-Inositol in Women with Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis
The practical takeaway is that MI is a reasonable first-line option, particularly for women who struggle with metformin’s gastrointestinal side effects (nausea, diarrhea, and cramping are common complaints). MI’s side effects, when they occur at all, tend to be mild and gastrointestinal, and a phase I safety study found it well tolerated at doses up to 18 grams per day, far above the typical supplement dose of 2 to 4 grams.13Cancer Epidemiology, Biomarkers & Prevention. A Phase I Study of myo-Inositol for Lung Cancer Chemoprevention
How MI Compares to Hormonal Contraceptives for Cycle Control
This comparison is a bit apples-to-oranges, because hormonal contraceptives (combined oral contraceptive pills, or COCs) don’t actually “regulate” your cycle. They replace it with a synthetic one. When you stop taking them, the underlying hormonal imbalance is still there. MI works differently, addressing the root metabolic problem rather than overriding it.
A randomized study in young women with PCOS compared MI plus DCI to combined hormonal contraceptives. After treatment, about 85% of women on the inositol combination resumed spontaneous menses, compared to all women on COCs having withdrawal bleeds (which are expected, since the pill produces them by design). Here’s what’s telling: three months after stopping treatment, roughly 86% of the MI group continued to cycle spontaneously, while only about 74% of the COC group did.14PubMed. Efficacy of myo-inositol and d-chiro-inositol combination on menstrual cycle regulation and improving insulin resistance in young women with polycystic ovary syndrome: A randomized open-label study The inositol group also saw improvements in insulin resistance, which the COC group did not. So while the pill gives you predictable monthly bleeding faster, MI may leave you in a better hormonal position once you stop.
How Long Before You See Results
Most clinical trials use treatment periods of two to six months. One study found that all amenorrheic and oligomenorrheic subjects restored menstrual cyclicity after 12 weeks of MI at 2 grams per day.15PubMed. Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study Other studies report meaningful improvements over three to six months. If you’ve been taking MI for six months without any change in cycle regularity, the supplement alone may not be sufficient for your situation, and it’s worth discussing additional or alternative approaches with a clinician.
The standard dose used across most studies is 2 grams of myo-inositol twice daily (4 grams total), often paired with 200 to 600 micrograms of folic acid. When D-chiro-inositol is included, the ratio used in research is 40:1 (MI to DCI), which mirrors the physiological ratio found in the body. This ratio matters: too much DCI relative to MI can actually impair egg quality in the ovaries, since the two forms have different roles in different tissues.
The MI and DCI Ratio Question
D-chiro-inositol works alongside MI but has distinct effects. In the ovary, MI supports FSH signaling and egg maturation. DCI, meanwhile, acts more on the insulin-signaling side and works as an aromatase inhibitor, influencing how androgens convert to estrogens.2Trends in Endocrinology & Metabolism. Physiologic Roles of Myo-Inositol and D-Chiro-Inositol in Polycystic Ovary Syndrome In the right proportion, this combination addresses both the ovarian and metabolic sides of PCOS simultaneously. The 40:1 ratio of MI to DCI has emerged as the standard in clinical practice and is what most supplements targeting PCOS use.
A study using this 40:1 combination found significant decreases in total testosterone, free testosterone, and LH, alongside increases in sex hormone-binding globulin and estradiol.16Gynecologic and Obstetric Investigation. The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria These are exactly the hormonal shifts that support regular ovulation. Taking MI alone still works for many women, but the combined formulation may offer a slight advantage for those with more pronounced insulin resistance or androgen excess.
Effects on Heavy or Prolonged Bleeding
While most research focuses on MI bringing absent or infrequent periods back, there is also emerging evidence that inositols can help on the other end of the spectrum: periods that are too heavy or last too long. A pilot study on D-chiro-inositol in women with endometrial hyperplasia (an abnormally thickened uterine lining, which causes heavy bleeding) found that treatment reduced endometrial thickness by about 26% at three months and roughly 36% at six months. The number of menstruation days dropped from about 9 to about 6, and days with heavy bleeding fell from about 5.5 at baseline to less than 1.5 at six months.17PubMed Central. D-Chiro-Inositol in Endometrial Hyperplasia: A Pilot Study
This is a small pilot study rather than definitive evidence, but it illustrates a broader point about how inositols seem to work: they don’t push the menstrual cycle in one direction. They nudge it toward normal function. If your periods are absent, MI helps bring them back. If your lining is overgrown and causing excessive bleeding, DCI may help normalize it. The effect is regulatory rather than suppressive or stimulatory.
Use in Adolescents
PCOS often first appears during adolescence, and irregular periods in teenagers are frequently brushed off as “just puberty adjusting.” When PCOS is the actual cause, early intervention matters. Myo-inositol has been studied in this age group and appears both effective and safe. A review of the evidence concluded that MI is a safe and effective way to prevent and correct metabolic disorders in teenagers with PCOS, and that combining MI with oral contraceptives enhanced the anti-androgenic effects while counterbalancing the weight gain that COCs sometimes cause.18PubMed Central. Myo-Inositol in the Treatment of Teenagers Affected by PCOS
Inositols are particularly appealing for younger patients because they carry minimal side effects and can be used long-term without the concerns that sometimes surround early and prolonged contraceptive use.19Academic Press. A Clinical Guide to Inositols For a teenager with PCOS who isn’t sexually active and doesn’t need contraception, MI offers a way to address the hormonal problem without introducing synthetic hormones.
What About Irregular Periods Not Caused by PCOS?
This is where the evidence gets thin. Nearly all the clinical research on MI and menstrual cycles has been conducted in women with PCOS. If your irregular periods are caused by something else, like hypothalamic amenorrhea (from stress, low body weight, or excessive exercise), thyroid dysfunction, hyperprolactinemia, or premature ovarian insufficiency, the research doesn’t clearly support MI as a treatment. MI’s mechanism targets insulin-driven hormonal imbalance, so it stands to reason that it would be less effective when insulin resistance isn’t part of the picture.
That said, MI’s role in FSH signaling means it could theoretically support ovarian function in other contexts. One study found that MI supplementation in non-PCOS women undergoing fertility treatment reduced the amount of FSH medication needed for ovarian stimulation.20PubMed Central. A retrospective study “myo-inositol is a cost-saving strategy for controlled ovarian stimulation in non-polycystic ovary syndrome art patients.” That’s not the same thing as regulating a natural cycle, but it suggests MI has ovarian effects beyond the PCOS population. For now, though, if your irregular periods aren’t linked to PCOS or insulin resistance, MI isn’t a well-supported solution. Getting a proper diagnosis of the underlying cause matters more than reaching for any supplement.
Myo-Inositol and Premenstrual Mood Symptoms
Beyond cycle regularity, MI has shown up in research on premenstrual dysphoric disorder (PMDD), the severe form of PMS that involves significant mood disruption in the days before a period. MI appears to act similarly to SSRI antidepressants, likely because it serves as a second messenger for serotonin in the brain. A clinical study found that MI significantly improved symptoms on multiple rating scales for depression and overall illness severity in women with PMDD.21PubMed. Myo-inositol in the treatment of premenstrual dysphoric disorder
This is a separate application from cycle regulation, but it’s relevant to anyone considering MI for menstrual health broadly. If your periods are regular but your premenstrual symptoms are debilitating, MI might still offer some benefit, though the evidence here is earlier-stage than the PCOS research.
Fertility Considerations When Your Cycle Returns
An important practical point that sometimes gets lost: if MI restores your ovulation, you can get pregnant. This might sound obvious, but women who have been anovulatory for months or years sometimes don’t register that a returning period means returning fertility. MI improves oocyte and embryo quality in PCOS in addition to restoring ovulation.22PubMed Central. Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies If pregnancy is your goal, that’s excellent news. If it isn’t, you need contraception once your cycles resume, even if you haven’t had a period in a long time.
Researchers have noted that while MI clearly improves ovulation rates and cycle regularity, the data on whether it actually increases clinical pregnancy rates and live births in assisted reproduction is still not robust enough to draw firm conclusions.1PubMed. Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta-analysis of randomised trials More ovulation doesn’t automatically translate to more babies, since pregnancy involves many steps beyond just releasing an egg. Still, restoring regular ovulation is a necessary first step for natural conception, and MI accomplishes that reliably in the PCOS population.